Monday, November 04, 2024
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

NEWS

Novavax anti-Covid-19 vaccine under study in Europe

Amsterdam, Nov 17 (Prensa Latina) The European Medicines Agency (EMA) began today, at the request of the European Union, the evaluation of the anti-Covid-19 vaccine of U.S. pharmaceutical Novavax.

This investigation will be carried out on an accelerated schedule, the EMA indicated, and explained that the opinion on the marketing authorization could be issued in a matter of weeks, according to the Dutch press on Wednesday.

The vaccine, which could become the fifth to be licensed in the European Union, uses a different technology from those already validated worldwide.

It is an immunogen based on proteins that trigger a virus-free response, and can be stored at a temperature of between 2 and 8 degrees Celsius, which would ease its distribution.

The WEA noted that the fast evaluation is due to the need to seek alternatives to face the new wave of Covid-19 in Europe.

ef/etc/mgt/gfa

LATEST NEWS
RELATED